■ Who are we?
Hangzhou Regenovo Biotechnology Co., Ltd. (Regenovo) is a supplier of 3D printing equipment and comprehensive solutions in the biomedical field. As a national high-tech enterprise, Regenovo is committed to developing professional bioprinting technologies and equipment for the biomedical field, building a digital medical chain from medical information to customized 3D printing of medical products, and possesses a dual-core industry consortium of "bioprinting + biomaterials", providing products and services for fields such as scientific research, regenerative medicine, tissue engineering, drug development, and personalized medicine.
In 2015, the company completed a Series A financing of RMB 30 million, and in 2017 a Series B financing of RMB 70 million, for the upgraded R&D and industrialization of biomaterial and cell 3D printing technologies, as well as the construction of a biomedical 3D printing manufacturing service center.
The company possesses a fully independent intellectual property rights bioprinting equipment and technology system, with more than 50 patented technologies.
Lead unit of the "13th Five-Year Plan" National Key R&D Program project "Bioprinting Technology for Personalized Implants and Interventional Devices"
Lead unit of the Zhejiang Provincial Key R&D Program project "Research and Application of Additive Manufacturing Technology for Medical Biomaterials"
Lead unit of the Zhejiang Provincial Key R&D Program project "Research on Key Technologies of Integrated 3D Bioprinters"
Lead unit of the Ministry of Science and Technology 863 Program project "Development of a Series of Bioprinting Technologies and Devices for Rapid Repair and Tissue/Organ Transplantation Applications"
We professionally provide:
Bioprinting equipment series, cell 3D printing and drug screening technologies, bioinks, biomaterials, and medical devices
Complex requirements, complete solutions:
Advanced cell 3D printing technology and equipment: 《Biomaterials》: "Fascinating state-of-the-art"
Tissue biomimetic culture technology and equipment: technology for regulating and inducing the structure and function of printed tissues
Systematic tissue and organ regeneration and repair technology: non-destructive testing, 3D reconstruction, and quantitative analysis technology for tissue organs and the internal microstructure of 3D printed tissues
Rich experience, reliable technical support:
3D printed functional liver lobules capable of small-batch production
3D printed artificial bone scaffolds completed animal testing
3D printed skin received support from the National 863 Program
3D printed high-throughput drug screening models
■ Our team
The work of the company's R&D team in the field of bioprinting has been evaluated by the international journal 《Biomaterials》 as "state-of-the-art in the field", and is a young and energetic team.
Selected as "2015 Forbes China Technology Pioneer", president unit of the "China 3D Printing Technology Industry Alliance", vice-chairman unit of the "Zhejiang Society for Translational Medicine", etc., and has successively undertaken a series of national projects (selected in the National Key R&D Program in 2017), holding more than 70 patents related to bioprinting technology and biomaterial technology.
Current partners of the company: Sichuan University, South China University of Technology, Peking University, Tsinghua University, Zhejiang University, Shanghai Jiao Tong University, Harbin Institute of Technology, Guangxi Medical University, National Taiwan University, City University of Hong Kong, Macau University of Science and Technology*, Chinese PLA General Hospital, West China Hospital of Sichuan University, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Affiliated Hospital of Logistics University of Chinese People's Armed Police Force, Chinese PLA General Hospital, Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Zhejiang Provincial People's Hospital, etc.
■ The rewards we prepare for you
Salary and bonuses: based on your abilities, we provide competitive salaries, two salary adjustment opportunities per year; R&D project awards, sales commission awards, company performance awards, year-end bonuses, options...
Benefits system: five social insurances and one housing fund plus supplementary commercial insurance, lunch allowance, communication allowance, transportation allowance, annual travel, department activities, holiday greetings, birthday greetings...
Others: through company training, promotion system, and rationalization proposals, you can come to the company to become a technical expert, R&D star, marketing master, or enterprise management expert; in short, we hope to meet your multi-channel growth requirements.
What does Hangzhou Regenovo Biotechnology Co., Ltd. require? Who is Hangzhou Regenovo Biotechnology Co., Ltd. hiring? recruitment: 销售类占比最多占28.8%,其次是生物/制药/化工/环保类占21.2%. What education can get in at ? 本科占比最多占62.1%,其次是硕士占15.2%. High education required at ? 硕士占15.2%. Work experience required at ? 不限占比最多占33.3%,其次是1-3年占31.8%. Where are the job locations at ? 杭州占比最多占89.4%,其次是上海占6.1%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows